Cytodyn had a CEO that kept things close to the the chest and there was a couple years of big dilution and debt creation and no progress in trials. his name was Tony, he was part of 13d. Nader may have had to put a little too much sizzle on the steak, but it did move things forward a lot. we would have nothing for sure without him. We can all armchair quarterback, but ask yourselves how would you raise the hundreds of millions to get one product through the FDA for one indication with no revenue a all. I sure could not do it.